-
Mercati
-
Azioni
Sustainable finance2025 Euronext ESG Trends ReportLeggi tuttoA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indici
Access the white paperInvesting in the future of Europe with innovative indicesLeggi tuttoThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETF
The European market place for ETFsEuronext ETF EuropeLeggi tuttoInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Fondi
-
Obbligazioni
European Defence BondsGroupe BPCE lists the first bondLeggi tuttoFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Prodotti strutturati
-
Derivati
Where European Government Bonds Meet the FutureFixed Income derivativesLeggi tuttoTrade mini bond futures on main European government bonds
-
Commodities
- Panoramica
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Consegna e liquidazione
- Specifiche e disposizioni
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesLeggi tuttoEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Documenti e risorse
Designed to help students navigate the complexities of financial marketsEuronext Trading gameLeggi tuttoJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
ORAGENICS
Identification
Listing sponsor / Euronext Growth Advisor
BRYAN, GARNIER AND CO Ltd
Ticker
ALONI
Codice ISIN
US6840231046
Mercato
Euronext Growth
Borsa
Paris
ICB
Biotechnology
Indirizzo web
http://www.onibiopharma.com
Indirizzo web
http://www.onibiopharma.com
Operation
Data IPO
Lun 15/12/2008
Tipologia IPO
Cotation directe
Tipologia IPO
Initial Public offering
Categoria
IPO
Procedura
- Nombre de titres à admettre : 38 318 478 - Cours de référence : cours de clotûre de l'action Oragenics du 12/12/2008 sur NYSE Alternext US, converti en EUR selon le taux de change du 12/12/2008.
Descrizione dell'operazione
Admission sur Alternext des 38 318 478 actions ordinaires composant le capital de la société
ORAGENICS. La société ORAGENICS, dont le nom commercial est ONI BioPharma, est par ailleurs cotée sur NYSE Alternext US.
Calendario
15 décembre 2008 : admission aux négociations des actions émises par ORAGENICS